Journal update monthly top five
The St. Vincent's Emergency Research Group has compiled a consensus review of five highly relevant papers from outside the core field of emergency medicine, which is useful for keeping us abreast of emerging guidelines in related areas like stroke care. Of these selections, the TRACE-5 trial stands out as a 'game changer,' specifically addressing basilar artery occlusion within 24 hours. This multicenter, randomized trial compared tenecteplase against standard medical management for this catastrophic posterior circulation event. The high rating suggests that the findings have significant implications and may necessitate changes in our current reperfusion protocols for acute stroke.
The St. Vincent's Emergency Research Group has compiled a consensus review of five highly relevant papers from outside the core field of emergency medicine, which is useful for keeping us abreast of emerging guidelines in related areas like stroke care. Of these selections, the TRACE-5 trial stands out as a 'game changer,' specifically addressing basilar artery occlusion within 24 hours. This multicenter, randomized trial compared tenecteplase against standard medical management for this catastrophic posterior circulation event. The high rating suggests that the findings have significant implications and may necessitate changes in our current reperfusion protocols for acute stroke.
Show moreShow less
Given the 'game changer' designation for TRACE-5, you should pay close attention to how tenecteplase compares to standard care for basilar artery occlusion within 24 hours. While this suggests a potential shift in posterior circulation management, remember that consensus reviews require careful integration of these findings into local protocols; do not assume immediate practice change without reviewing the full methodology and limitations.